A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(24 sites)

United States

The University of Alabama at Birmingham, Birmingham, Alabama

UC Davis School of Medicine, Sacramento, California

Childrens Hospital Colorado, Aurora, Colorado

Advocate Children's Hospital, Park Ridge, Illinois

University of Iowa Hospital and Clinics, Iowa City, Iowa

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

University of Cincinnati, Cincinnati, Ohio

Oregon Health And Science University, Portland, Oregon

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

University of Texas Medical Branch, Galveston, Texas

Austria

Medizinische Universitaet Graz, Graz

Medical University Vienna, Vienna

Germany

Universitaetsklinikum Giessen und Marburg GmbH, Giessen

Medizinische Hochschule Hannover, Hanover

Universitatsklinikum Jena, Jena

Universitaetsklinikum Tuebingen, Tübingen

Netherlands

Leiden University Medical Center, Leiden

Poland

Instytut Centrum Zdrowia Matki Polki, Lodz

Instytut Matki i Dziecka, Warsaw

Panstwowy Instytut Medyczny MSWiA w Warszawie, Warsaw

United Kingdom

Birmingham Women's Hospital, Birmingham

Liverpool Women's NHS Foundation Trust - Liverpool Women's Hospital, Liverpool

Queen Charlotte's and Chelsea Hospital, London

John Radcliffe Hospital, Oxford